Abstract
In the presence of ginkgolides A and B a recombinant human prion protein (90-231) is more susceptible to proteolysis, which is characteristic for the non-infective form of prion proteins and more thermostable than in the absence of ginkgolides. Probably, ginkgolides exert a neuroprotective effect through a rearrangement of the prion structure.
Keywords: Three-dimensional structure, structural transformation, ginkgolide, prion protein, protein misfolding
Protein & Peptide Letters
Title: Interactions of Ginkgolides A and B with a Recombinant Human Prion Protein
Volume: 17 Issue: 3
Author(s): Dessislava Georgieva, Lars Redecke, Martin von Bergen, Nicolay Genov and Chrsitian Betzel
Affiliation:
Keywords: Three-dimensional structure, structural transformation, ginkgolide, prion protein, protein misfolding
Abstract: In the presence of ginkgolides A and B a recombinant human prion protein (90-231) is more susceptible to proteolysis, which is characteristic for the non-infective form of prion proteins and more thermostable than in the absence of ginkgolides. Probably, ginkgolides exert a neuroprotective effect through a rearrangement of the prion structure.
Export Options
About this article
Cite this article as:
Georgieva Dessislava, Redecke Lars, Bergen von Martin, Genov Nicolay and Betzel Chrsitian, Interactions of Ginkgolides A and B with a Recombinant Human Prion Protein, Protein & Peptide Letters 2010; 17 (3) . https://dx.doi.org/10.2174/092986610790780314
DOI https://dx.doi.org/10.2174/092986610790780314 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Thrombus Extraction Catheters vs. Angiojet Rheolytic Thrombectomy in Thrombotic Lesions/SV Grafts
Current Cardiology Reviews Aldose Reductase in Diabetic Microvascular Complications
Current Drug Targets Serum Vitamin D and Cingulate Cortex Thickness in Older Adults: Quantitative MRI of the Brain
Current Alzheimer Research Biomedical Applications of Accelerator Mass Spectrometry
Current Analytical Chemistry Current Treatment of the Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
Cardiovascular & Hematological Disorders-Drug Targets Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced Men
Current HIV Research Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Prevention of Cell Damage in Ischaemic-Reperfusion: Mitochondrial Respiratory Chain as a Pharmacological Target
Letters in Drug Design & Discovery Fluid Retention and Rostral Fluid Shift in Sleep-Disordered Breathing
Current Hypertension Reviews Optimisation of Synthetic Vector Systems for Cancer Gene Therapy – The Role of the Excess of Cationic Dendrimer Under Physiological Conditions
Current Topics in Medicinal Chemistry Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill
Current Medicinal Chemistry Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology
Current Drug Delivery Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Current Pharmaceutical Design The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Current Vascular Pharmacology Recent Advances in Biomaterials for Tissue Engineering and Controlled Drug Delivery
Current Pharmaceutical Biotechnology Recent Strategies Combining Biomaterials and Stem Cells for Bone, Liver and Skin Regeneration
Current Stem Cell Research & Therapy Biofilms: An Extra Hurdle for Effective Antimicrobial Therapy
Current Pharmaceutical Design Mechanisms of Liver Injury: An Overview
Current Molecular Medicine